Literature DB >> 32895736

Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns.

Andrew J Dodgshun1, Kohei Fukuoka2, Melissa Edwards2, Vanessa J Bianchi3, Anirban Das2, Alexandra Sexton-Oates4, Valérie Larouche5, Magimairajan I Vanan6, Scott Lindhorst7, Michal Yalon8, Gary Mason9, Bruce Crooks10, Shlomi Constantini11, Maura Massimino12, Stefano Chiaravalli12, Jagadeesh Ramdas13, Warren Mason14, Shamvil Ashraf15, Roula Farah16, An Van Damme17, Enrico Opocher18, Syed Ahmer Hamid15, David S Ziegler19, David Samuel20, Kristina A Cole21, Patrick Tomboc22, Duncan Stearns23, Gregory A Thomas24, Alexander Lossos25, Michael Sullivan26, Jordan R Hansford26, Alan Mackay27, Chris Jones27, David T W Jones28, Vijay Ramaswamy2, Cynthia Hawkins2, Eric Bouffet2, Uri Tabori29.   

Abstract

Replication repair deficiency (RRD) leading to hypermutation is an important driving mechanism of high-grade glioma (HGG) occurring predominantly in the context of germline mutations in RRD-associated genes. Although HGG presents specific patterns of DNA methylation corresponding to oncogenic mutations, this has not been well studied in replication repair-deficient tumors. We analyzed 51 HGG arising in the background of gene mutations in RRD utilizing either 450 k or 850 k methylation arrays. These were compared with HGG not known to be from patients with RRD. RRD HGG harboring secondary mutations in glioma genes such as IDH1 and H3F3A displayed a methylation pattern corresponding to these methylation subgroups. Strikingly, RRD HGG lacking these known secondary mutations clustered together with an incompletely described group of HGG previously labeled "Wild type-C" or "Paediatric RTK 1". Independent analysis of two comparator HGG cohorts showed that other RRD/hypermutant tumors clustered within these subgroups, suggesting that undiagnosed RRD may be driving some HGG clustering in this location. RRD HGG displayed a unique CpG Island Demethylator Phenotype in contrast to the CpG Island Methylator Phenotype described in other cancers. Hypomethylation was enriched at gene promoters with prominent demethylation in genes and pathways critical to cellular survival including cell cycle, gene expression, cellular metabolism, and organization. These data suggest that methylation arrays may provide diagnostic information for the detection of RRD HGG. Furthermore, our findings highlight the unique natural selection pressures in these highly dysregulated, hypermutant cancers and provide the novel impact of hypermutation and RRD on the cancer epigenome.

Entities:  

Keywords:  DNA methylation; DNA mismatch repair; DNA repair; Glioblastoma; Glioma

Mesh:

Year:  2020        PMID: 32895736     DOI: 10.1007/s00401-020-02209-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  5 in total

1.  Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.

Authors:  Patrick J Cimino; Courtney Ketchum; Rust Turakulov; Omkar Singh; Zied Abdullaev; Caterina Giannini; Peter Pytel; Giselle Yvette Lopez; Howard Colman; MacLean P Nasrallah; Mariarita Santi; Igor Lima Fernandes; Jeff Nirschl; Sonika Dahiya; Stewart Neill; David Solomon; Eilis Perez; David Capper; Haresh Mani; Dario Caccamo; Matthew Ball; Michael Badruddoja; Rati Chkheidze; Sandra Camelo-Piragua; Joseph Fullmer; Sanda Alexandrescu; Gabrielle Yeaney; Charles Eberhart; Maria Martinez-Lage; Jie Chen; Leor Zach; B K Kleinschmidt-DeMasters; Marco Hefti; Maria-Beatriz Lopes; Nicholas Nuechterlein; Craig Horbinski; Fausto J Rodriguez; Martha Quezado; Drew Pratt; Kenneth Aldape
Journal:  Acta Neuropathol       Date:  2022-10-22       Impact factor: 15.887

2.  Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.

Authors:  Hyunhee Kim; Ka Young Lim; Jin Woo Park; Jeongwan Kang; Jae Kyung Won; Kwanghoon Lee; Yumi Shim; Chul-Kee Park; Seung-Ki Kim; Seung-Hong Choi; Tae Min Kim; Hongseok Yun; Sung-Hye Park
Journal:  Lab Invest       Date:  2021-11-30       Impact factor: 5.662

3.  Immune cell deconvolution of bulk DNA methylation data reveals an association with methylation class, key somatic alterations, and cell state in glial/glioneuronal tumors.

Authors:  Omkar Singh; Drew Pratt; Kenneth Aldape
Journal:  Acta Neuropathol Commun       Date:  2021-09-08       Impact factor: 7.801

4.  PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas.

Authors:  Kirsi J Rautajoki; Serafiina Jaatinen; Aliisa M Tiihonen; Matti Annala; Elisa M Vuorinen; Anni Kivinen; Minna J Rauhala; Kendra K Maass; Kristian W Pajtler; Olli Yli-Harja; Pauli Helén; Joonas Haapasalo; Hannu Haapasalo; Wei Zhang; Matti Nykter
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

5.  Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.

Authors:  Abigail K Suwala; Damian Stichel; Daniel Schrimpf; Matthias Kloor; Annika K Wefers; Annekathrin Reinhardt; Sybren L N Maas; Christian P Kratz; Leonille Schweizer; Martin Hasselblatt; Matija Snuderl; Malak Sameer J Abedalthagafi; Zied Abdullaev; Camelia M Monoranu; Markus Bergmann; Arnulf Pekrun; Christian Freyschlag; Eleonora Aronica; Christof M Kramm; Felix Hinz; Philipp Sievers; Andrey Korshunov; Marcel Kool; Stefan M Pfister; Dominik Sturm; David T W Jones; Wolfgang Wick; Andreas Unterberg; Christian Hartmann; Andrew Dodgshun; Uri Tabori; Pieter Wesseling; Felix Sahm; Andreas von Deimling; David E Reuss
Journal:  Acta Neuropathol       Date:  2020-11-20       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.